We are live on
!
Find out more
OCM
Osterweis Capital Management Portfolio holdings
AUM
$1.94B
1-Year Est. Return
20.77%
This Fund
S&P 500
This Quarter
Est. Return
+11.43%
1 Year Est. Return
+20.77%
3 Year Est. Return
+69.82%
5 Year Est. Return
+88.03%
10 Year Est. Return
+482.02%
AUM
$1.7B
AUM Growth
+$127M
(+8.1%)
Cap. Flow
-$195M
Cap. Flow
% of AUM
-11.44%
Top 10 Holdings %
Top 10 Hldgs %
33.14%
Holding
208
New
16
Increased
24
Reduced
75
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$8.75M |
| 2 |
Adobe
ADBE
|
+$7.75M |
| 3 |
Duolingo
DUOL
|
+$7.16M |
| 4 |
SKX
Skechers
SKX
|
+$7.16M |
| 5 |
FOLD
Amicus Therapeutics
FOLD
|
+$6.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$16.8M |
| 2 |
Microsoft
MSFT
|
+$9.45M |
| 3 |
Ametek
AME
|
+$8.24M |
| 4 |
Insulet
PODD
|
+$7.79M |
| 5 |
RBC Bearings
RBC
|
+$7.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.97% |
| 2 | Healthcare | 16.08% |
| 3 | Industrials | 11.11% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Consumer Staples | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Vulcan Materials
VMC
$36.8B
| $5.46K | ﹤0.01% |
20
+10
| +100% | +$2.46K |
|
177
BridgeBio Pharma
BBIO
$16.6B
| – | – |
-88,485
| Closed | -$3.57M |
|
|
BPT
178
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| – | – |
-120
| Closed | -$296 |
|
179
CAVA Group
CAVA
$7.14B
| – | – |
-73,995
| Closed | -$3.18M |
|
180
Cytokinetics
CYTK
$10.4B
| – | – |
-17,340
| Closed | -$1.45M |
|
181
FIVE9
FIVN
$2.51B
| – | – |
-79,690
| Closed | -$6.27M |
|
182
Madrigal Pharmaceuticals
MDGL
$11.8B
| – | – |
-15,147
| Closed | -$3.5M |
|
183
3M
MMM
$93.7B
| – | – |
-90
| Closed | -$8.2K |
|
184
Motorola Solutions
MSI
$75.9B
| – | – |
-14
| Closed | -$4.38K |
|
185
Procore
PCOR
$8.81B
| – | – |
-41,545
| Closed | -$2.88M |
|
|
186
Insulet
PODD
$9.92B
| – | – |
-35,881
| Closed | -$7.79M |
|
|
187
RBC Bearings
RBC
$17.8B
| – | – |
-27,229
| Closed | -$7.76M |
|
188
Remitly
RELY
$4.97B
| – | – |
-119,185
| Closed | -$2.31M |
|
189
Virgin Galactic
SPCE
$397M
| – | – |
-23
| Closed | -$1.1K |
|
190
Constellation Brands
STZ
$22.8B
| – | – |
-250
| Closed | -$60.4K |
|
191
Veralto
VLTO
$23.8B
| – | – |
-7
| Closed | -$576 |
|
192
Zurn Elkay Water Solutions
ZWS
$8.49B
| – | – |
-180,505
| Closed | -$5.31M |
|
|
AXNX
193
DELISTED
Axonics, Inc. Common Stock
AXNX
| – | – |
-103,614
| Closed | -$6.45M |
|
|
AYX
194
DELISTED
Alteryx Inc
AYX
| – | – |
-2,000
| Closed | -$94.3K |
|
Similar funds
AAA
FFH
BC
HCL
HC
CC
FC
DCM
Osterweis Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Osterweis Capital Management held 208 positions worth $1.7B, up 8.1% from $1.58B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Osterweis Capital Management withdrew a net $195M in Q1 2024, closing 18 positions and reducing 75 holdings. Its most notable exit was Insulet, an estimated $7.79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Osterweis Capital Management opened a new position in Bio-Techne worth $8.61M.
- Osterweis Capital Management's largest Q1 2024 buy was Bio-Techne: 122,328 shares worth $8.61M.
- Osterweis Capital Management added most to Adobe in Q1 2024, an estimated $7.75M increase.
- Osterweis Capital Management's biggest Q1 2024 reduction was Kenvue, cutting an estimated $16.8M.
- Osterweis Capital Management fully exited Insulet in Q1 2024, selling an estimated $7.79M.
- Osterweis Capital Management's ten largest holdings make up 33% of its $1.7B portfolio in Q1 2024.
- Osterweis Capital Management opened 16 new positions and closed 18 in Q1 2024.
- Osterweis Capital Management's portfolio value rose 8.1% quarter-over-quarter to $1.7B.
Based on Osterweis Capital Management's 13F filing for Q1 2024, filed 15 May 2024.